| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 138, 119-128, Copyright © 1991 by American Society for Investigative Pathology
REGULAR ARTICLES |
RB Nagle, MK Brawer, J Kittelson and V Clark
Department of Pathology, University of Arizona, Tucson.
Thirty-one snap-frozen human prostate specimens containing examples of benign hyperplasia, prostatic intraepithelial neoplasia (PIN), and invasive carcinoma were analyzed using a panel of 24 antibodies and one lectin. Twenty-seven additional routinely processed radical prostatectomy specimens were studied using selected probes known to work on formalin-fixed paraffin-embedded material. Three probes, anticytokeratin KA4, anti-vimentin V9, and the lectin from Ulex europaeus (UEA-1), demonstrated phenotypic similarities between PIN and invasive carcinoma. Whereas the luminal cells of normal or hyperplastic prostatic epithelium are minimally reactive with KA4 (4%) or UEA-1 (0%) and strongly reactive with anti-vimentin (91%), both the PIN and invasive carcinoma are reactive with KA4 (89% and 93%, respectively) and UEA-1 (96% and 93%, respectively) and minimally reactive with anti- vimentin (15% and 0%, respectively). The increased KA4 staining was shown to be in part due to detection of cytokeratin 19, by using cytokeratin-19-specific antibodies, 4.62 and LP2K. The reasons for the increased expression of this cytokeratin and the decreased expression of vimentin are unclear but seem to indicate a phenotypic relationship between the PIN lesions and invasive carcinoma.
This article has been cited by other articles:
 |
|
 |
|
  N. Sharifi, R. J Lechleider, and W. L Farrar Transforming growth factor-{beta} receptor III downregulation in prostate cancer: is inhibin B a tumor suppressor in prostate? J. Mol. Endocrinol., November 1, 2007; 39(5): 329 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Ippolito, J. Xu, S. Jain, K. Moulder, S. Mennerick, J. R. Crowley, R. R. Townsend, and J. I. Gordon An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers PNAS, July 12, 2005; 102(28): 9901 - 9906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Alge, S. Suppmann, S. G. Priglinger, A. S. Neubauer, C. A. May, S. Hauck, U. Welge-Lussen, M. Ueffing, and A. Kampik Comparative Proteome Analysis of Native Differentiated and Cultured Dedifferentiated Human RPE Cells Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3629 - 3641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Hudson, A. T. Guy, P. Fry, M. J. O'Hare, F. M. Watt, and J. R.W. Masters Epithelial Cell Differentiation Pathways in the Human Prostate: Identification of Intermediate Phenotypes by Keratin Expression J. Histochem. Cytochem., February 1, 2001; 49(2): 271 - 278. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. T. Collins, F. K. Habib, N. J. Maitland, and D. E. Neal Identification and isolation of human prostate epithelial stem cells based on {alpha}2{beta}1-integrin expression J. Cell Sci., January 11, 2001; 114(21): 3865 - 3872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Abate-Shen and M. M. Shen Molecular genetics of prostate cancer Genes & Dev., October 1, 2000; 14(19): 2410 - 2434. [Full Text]
|
|
|
|
|
|
R. P. Casaroli-Marano, R. Pagan, and S. Vilaro Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy: Intermediate Filament Protein Expression in Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., August 1, 1999; 40(9): 2062 - 2072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Pankov, I Simcha, M Zoller, R. Oshima, and A Ben-Ze'ev Contrasting effects of K8 and K18 on stabilizing K19 expression, cell motility and tumorigenicity in the BSp73 adenocarcinoma J. Cell Sci., January 4, 1997; 110(8): 965 - 974. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
